vascular biogenics ltd. is a biotechnology company located in 6yonatan netanyahu street, yehud, center district, israel.
Company profile
Ticker
NTBL
Exchange
Website
CEO
Dror Harats
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Vascular Biogenics Ltd.
SEC CIK
Corporate docs
Subsidiaries
VBL Inc. ...
NTBL stock data
Latest filings (excl ownership)
8-K
Submission of Matters to a Vote of Security Holders
25 Mar 24
8-K
Changes in Registrant's Certifying Accountant
21 Mar 24
8-K
Other Events
22 Feb 24
DEF 14A
Definitive proxy
16 Feb 24
PRE 14A
Preliminary proxy
5 Feb 24
8-K
Changes in Registrant's Certifying Accountant
2 Feb 24
RW
Registration withdrawal request
8 Jan 24
8-K
Other Events
18 Dec 23
8-K/A
Financial Statements and Exhibits
29 Nov 23
8-K/A
Financial Statements and Exhibits
29 Nov 23
Transcripts
NTBL
Earnings call transcript
2022 Q1
17 May 22
NTBL
Earnings call transcript
2021 Q4
23 Mar 22
NTBL
Earnings call transcript
2021 Q3
15 Nov 21
NTBL
Earnings call transcript
2021 Q2
16 Aug 21
NTBL
Earnings call transcript
2021 Q1
11 May 21
NTBL
Earnings call transcript
2020 Q4
25 Mar 21
NTBL
Earnings call transcript
2020 Q3
16 Nov 20
NTBL
Earnings call transcript
2020 Q2
13 Aug 20
NTBL
Earnings call transcript
2020 Q1
14 May 20
NTBL
Earnings call transcript
2019 Q4
19 Mar 20
Latest ownership filings
4
Peter Feinberg
26 Jan 24
4
Tuomo Patsi
26 Jan 24
4
Michele Galen
26 Jan 24
4
Thomas Graney
26 Jan 24
4
THOMAS I H DUBIN
26 Jan 24
4
YEHUDA MICHAEL RICE
26 Jan 24
SC 13G/A
FR Capital Holdings, L.P.
11 Jan 24
4
Change in insider ownership
3 Jan 24
4
Change in insider ownership
2 Jan 24
4
Change in insider ownership
28 Dec 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 20.77 mm | 20.77 mm | 20.77 mm | 20.77 mm | 20.77 mm | 20.77 mm |
Cash burn (monthly) | 1.17 mm | (no burn) | 334.67 k | 662.83 k | 1.20 mm | 1.20 mm |
Cash used (since last report) | 6.96 mm | n/a | 2.00 mm | 3.96 mm | 7.15 mm | 7.15 mm |
Cash remaining | 13.81 mm | n/a | 18.77 mm | 16.81 mm | 13.62 mm | 13.62 mm |
Runway (months of cash) | 11.8 | n/a | 56.1 | 25.4 | 11.4 | 11.4 |
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 18 |
Opened positions | 7 |
Closed positions | 3 |
Increased positions | 1 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 162.78 mm |
Total shares | 9.39 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Aurum Ventures M.K.I. | 6.84 mm | $13.47 mm |
Slager David Mark | 1.81 mm | $2.38 mm |
MS Morgan Stanley | 327.01 k | $75.21 mm |
Group One Trading | 127.29 k | $29.28 mm |
VIRT Virtu Financial | 79.89 k | $18.00 k |
Geode Capital Management | 40.32 k | $9.27 mm |
Catalyst Financial Partners | 39.00 k | $8.97 mm |
Two Sigma Investments | 32.90 k | $7.57 mm |
Advisor | 22.49 k | $5.20 mm |
HBK Sorce Advisory | 20.58 k | $4.73 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
24 Jan 24 | Yehuda Michael Rice | Stock Option Ordinary Shares | Grant | Acquire A | No | No | 1.28 | 6,534 | 8.36 k | 6,534 |
24 Jan 24 | Thomas I H Dubin | Stock Option Ordinary Shares | Grant | Acquire A | No | No | 1.28 | 9,753 | 12.48 k | 9,753 |
24 Jan 24 | Michele Galen | Stock Option Ordinary Shares | Grant | Acquire A | No | No | 1.28 | 9,753 | 12.48 k | 9,753 |
24 Jan 24 | Thomas Graney | Stock Option Ordinary Shares | Grant | Acquire A | No | No | 1.28 | 9,753 | 12.48 k | 9,753 |
24 Jan 24 | Peter Feinberg | Stock Option Ordinary Shares | Grant | Acquire A | No | No | 1.28 | 9,753 | 12.48 k | 9,753 |